Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 11.31 is 96% above its 2-year average of 5.78, near the high end of its 2-year range (0.00–11.32).
As of the fiscal period ended Tuesday, June 30, 2026. 26.97% above its 12-month average of 8.91.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.31.
QUICK RATIO (ACID-TEST)
11.31
QUICK RATIO (ACID-TEST) AVG TTM
8.91
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+26.97%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 635 covered companies
CURRENT VS SECTOR MEDIAN
+278.26%
vs the sector median at left
BillionToOne, Inc.
Market Cap
$4.64B
Quick Ratio (Acid-Test)
11.31
TTM Avg
8.91
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.65B
Quick Ratio (Acid-Test)
1.38
TTM Avg
1.51
3Y Avg
1.37
5Y Avg
1.40
Market Cap
$4.68B
Quick Ratio (Acid-Test)
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
Market Cap
$4.64B
Quick Ratio (Acid-Test)
0.98
TTM Avg
1.08
3Y Avg
1.21
5Y Avg
1.19
Market Cap
$4.81B
Quick Ratio (Acid-Test)
38.51
TTM Avg
25.63
3Y Avg
37.00
5Y Avg
29.64
Market Cap
$4.81B
Quick Ratio (Acid-Test)
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.86B
Quick Ratio (Acid-Test)
2.74
TTM Avg
2.74
3Y Avg
3.13
5Y Avg
4.87
Market Cap
$4.43B
Quick Ratio (Acid-Test)
4.68
TTM Avg
3.02
3Y Avg
3.88
5Y Avg
4.28
Market Cap
$4.42B
Quick Ratio (Acid-Test)
0.66
TTM Avg
0.63
3Y Avg
0.81
5Y Avg
1.13
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BillionToOne, Inc. (BLLN) | $4.64B | 11.31 | 8.91 | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.65B | 1.38 | 1.51 | 1.37 | 1.40 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.68B | 6.95 | 6.77 | 6.23 | 10.87 |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 0.98 | 1.08 | 1.21 | 1.19 |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.81B | 38.51 | 25.63 | 37.00 | 29.64 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.81B | 26.10 | 14.27 | 14.23 | 14.47 |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.86B | 2.74 | 2.74 | 3.13 | 4.87 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.43B | 4.68 | 3.02 | 3.88 | 4.28 |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.42B | 0.66 | 0.63 | 0.81 | 1.13 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.36B | 5.08 | 3.83 | 4.06 | 4.06 |
Quick Ratio
11.31
Excludes inventory
Current Ratio
11.69
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 11.31 |
| 2026-03-31 | 10.58 |
| 2025-12-31 | 11.32 |
| 2025-09-30 | 5.75 |
| 2025-06-30 | 5.58 |
| 2025-03-31 | 5.58 |
| 2024-12-31 | 7.72 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
